$KYNC: People need to START Sending emails to Rick everyday. We need a Substantive PR & an 'X'-Space to show S/Hs the progress.

$TONR: Zoey: Thanks! I thought it would be more like '8' weeks...
It's 2x that time!
We'll see many leave.
2's & 3's in the Short Term.
Hoping we don't see 1's.
EOY...seems like, for any dreams of Penny land.

$USEI: Anyone spoken to Tony recently?
MJ is heating up BIG TIME!
He's got a real chance to get this ticker up & running now, more than ever.

$KYNC:Demoman: MoonPay & PayPal in the NEWS!
One could buy crypto using Paypal via Moonpay!

WTF is Rick doing?

$TONR: Shonnville: We'll trade 2's & 3's until FINS are audited for full SEC reporting status.
It'll take at least '6' to '8' weeks maybe more.
But it's worth the wait!

$SHMN: HL: Definitely they [CoStar + SoHM] have an Investment from
some deep pockets [Bio-Tech PubCo?]

Don't read too much into this.....
I noticed that the V.C. who comes up as part of the company [CoStar] : Haolin Sung from Taiwan, is also funding BioEclipse Therapeutics.
I personally know someone from BioEclipse [Startup Co]
Both could be bagging some POs from a PubCo.Illumina [$ILMN] comes up on pubs & Recent Research on mRNA delivery using Red-Blood Cell Membranes, as CoStar is currently doing.

I think $SHMN is close to putting out a PR. Let's see......

$KYNC: Mateo: I sent Rick a txt yesterday.
I'll send him one... shortly.
Hope he hasn't changed his phone number!
Have a good weekend!

$KYNC: Mateo: DemoMAN: Just sent Rick an email.

Will do this EVERYDAY...Multiple times!

$KYNC: Mateo: Can you publish his Ph number?
Thanks!

$TONR: train21: You're right. It must be tough to swallow for folks that bought in, in high trips or higher.
I see 1's to no bid....even

This looks to be a carefully orchestrated plan
1. Hype the ticker, via social media.
2. Bring in (implicitly) some pumpers like we see here
3. CJM does a great X-space show to pump the stock even further
a. No R/S
b. TWO Mergers (over $120M in
Revenue)!
c. Appoints "interim CEO"...who
doesn't.
have a public professional
presence (LinkedIn etc)
d. Makes big $ & exits

The future will likely be
4. New CEO (Celeb) who will recommend
R/S !
Retail will GET Screwed! As they pass the buck right in front of our eyes!
They may show some revenue, but insiders will benefit NOT retail....as usual!

$KYNC: DemoMAN: Chk your PM dude.
And reply back.
Thanks!

$SHMN:HL: I'd like to see these👇️guys '1' thro' '3' OWN some SHS!

***I have a feeling that the company is setting up a base for real investor interest in $SHMN
via some very REAL Business dealings with Companies [Incl Japanese Co's]
Surely after all this time it's NOT the same Old B.S. tweets?

I've talked about Dr. Bhatt in many of my posts earlier this year. He's well known & respected.
And apparently, he put his $ where his EXPERTISE is!

Why would they pass up an Opportunity like this?
Also:- S/Hs want to see what Barron's Stake is in $SHMN?

1. Mark Stevens, Science Advisor:

2. Eddie Chung, Coastar CEO:

3. Eric Furman, Ph.D. Knobbe Martens Sohm Intellectual Property Attorney:

4. Dr. Krishna Bhatt, Chief Medical Advisor, Bioscientist and Cardiologist:
Current owner of 82 Million Common shares, and recent Preferred Shares in exchange for Funding.

$KYNC: Matteo: DemoMAN: Have you guys emailed Rick?
rickwmt@gmail.com

Also Matteo your posts on 'X' are still up there. I'm still waiting for my 'X' account to be restored.

I'll harass them on a daily basis, as soon as they approve :>))

$PLPL: Anyone else seeing issues in TDA? TOS.
$PLPL comes up as PLPLE ...but NOT loading charts & data!

********NEVER MIND! :>)))

$USEI: Acme: Thanks for sharing! I'll check it out.
BTW Have you touched base with Tony?
It would be AWESOME to get $USEI current
especially with Crypto on fire.

$KYNC: Mateo: Who deleted your post?

$KYNC: Demo: Here's Rick's email address 👇

rickwmt@gmail.com

Mateo:- I don't see your tweet to Rick/$KYNC on 'X'.
I'm using my brother's 'X' account to read.
So I can't send anything.

$SHMN: MPSTOCK: It's NOT your fault. Mktg needs to do a better job.
URGENCY is IMPORTANT.

>>I just don’t see a catalyst right now that will move the price up
1. The CATALYSTS have been clearly communicated 👇️

The company is actively exploring, negotiating, and collaborating with several Japanese companies to expand its business.

This expansion includes the utilization of gene-editing technology called ABBIE, as well as licensing opportunities.

The management remains committed to…

— SOHM, Inc. (@sohminc) March 19, 2024

And we're EXPECTING developments [not just updates in a few weeks]; ABBIE results have been
presented at AACR24, peer reviewed pubs.

2. This is NOT some '10' yr old tech [as some '10' yr. old brain stated].The person is CLUELESS about
the SINGLE most IMPORTANT thing for Gene-Editing [Plant /Human use], i.e., Off-Target Limitations & unwanted mutations resulting in cancer etc.
Can't use ChatGPT & think they know everything! It's an Experiential acquisition.
Moreover, '10' yr. Old tech in Gene-Editing is ONLY now coming to fruition, via FDA approvals.
The ONE thing that can't be done is to predict Success/Failure, by how some company sold off ABBIE, B/C they
were sure it won't work! It takes Several Hundred $Millions to find out how & why it would work, in one area vs others.
TIME, $ & Statistics are key,NOT some dumb-A** opinion, about "10" yr old tech.
That's the most dumbest thing I've heard here!
We're talking about Permutations & Combinations in the 10's of Millions! And that's why there is a PROTOCOL for DESIGN, TESTING & V&V
And what's good in one area, may fail in another area [case in point, Genentech's AVASTIN, failed as a breast cancer drug, but is a major success in
many other therapies...making > $5B for Roche every year! This is just ONE Drug!

**********************************************************************************************************
ABBIE is resolving off-target edits by using the latest advances in:
-- Enzymes,
-- Guide RNA and
-- Cell or tissue-specific delivery.

ABBIE is able to significantly improve gene-editing precision with improved systems for DNA insertion.
ABBIE’s cell engineering tools and systems can reduce incidences of off-target edits by:
-- not inducing double-stranded breaks
**********************************************************************************************************

$SHMN: I can't repeat this ENOUGH...

Company needs to up the Marketing Ante on their peer reviewed results..
Genentech spent ~3Billion on AVASTIN [one of the use cases was for Wet AMD].
They also got sued B/C AVASTIN performed horribly in breast cancer for women.

All of the above was W/O the ability nor benefit of gene-Editing nor feedback from reading back edited DNA via NextGEN Seq.

There are companies out there that will THROW $100's of Millions, now that CRISPR is FDA approved.
No more MoUs & LOIs etc...ask for Investment & Committed POs.
Have a Good Weekend.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174227148

$SHMN: HL: Anyone with access to SoHM...Please pass this on to Aguilar & Gallegos...ASAP

1. Electroporation alters Phenotypes & also does NOT offer the highest yields to
a. Cell Health
b. Maximizing Payload ["Viral Vector"]
c. Efficiency & Yield of Payload Delivery

Have you looked at cutting edge alternatives to Electroporation? Why constrain yourself to Old-Tech?
Maybe get a FREE TRIAL [for data generation from👇️]
https://www.cellfebiotech.com/how-it-works/
I have NO affiliation to 👆️
2. If you're using a FACS type cell sorter [per your poster] for CD34, then you would be prone to a certain % of error due to
Phenotype changes.

If you need to know who I am...we'll talk thro' Julio M Clark.

And Pls...F*ing publish a Hi-RES POSTER of what you presented at AACR! WTF is Barron trying to hide here!
WTF is your mkt-ing dept doing? Twiddling thumbs?

$KYNC: Matteo: Just ask them what the heck are they up to?
And what's the plan?
Also:- Time to hold an 'X' space conference for S/Hs.
Thanks!

$SHMN: MDP: One of us seems to have SUCCESSFULLY convinced ourselves that he/She is a EXPERT at DNA Science, FDA, Pharma Cos ....etc ..

The other one has a track record of being an exec in afore mentioned Co's in CA.

$SHMN:MDP: You're running too many ASSUMPTIONS... just pure B.S & guessing!
1. Stallion Labs chose $SHMN as their SOLE distributor in N.America (that's a huge mkt)
2. Vol & Vol discounts are a Non-Issue. You need to check out the company (Stallion Labs). They'll provide both,
3. Medical Facility? $SHMN PR'd in Dec '23 that they've been REGISTERED with the U.S. FDA as both mfg & distribution facility.
So it's a NON-ISSUE!

The issues that I (&others) have are:-
1. Need Ms. Jacob to be Pro-Active & get the website updated, as a real co. with RESEARCH FACILITIES!
I believe that's ONE of her core responsibilities
2. Barron & Tony need to update S/Hs on sales & mkt initiatives. I believe Tony's core responsibility is sales (subset of Finance)
3. As was obvious Dr. Aguilar & Gallegos have been grinding away. Thank you to both! And Aguilar...looks to be working on the mkt too!

We're past the '90' day review period. So it's TIME to REVIEW PERFORMANCE!
This is NOT the FEDERAL GOVT!

$KYNC: Matteo: Are you active on Twitter? 'X'
I don't have an account.
But it would be good to ask questions publicly.

$SHMN: Drugmanrx: Presumably early in Jan...Dr. Aguilar presented the results from ABBIE
to "Several Japanese Companies"
These results [& updates] were presented at AACR2024

FYI...No company is allowed into a Scientific Conference without Peer reviewed material/results. Can't just walk in with a word doc/excel spreadsheet!
Hoping that real decision makers [the ones that sign P.O.s] are being shown in the videos.
Even if ABBIE is a TOTAL FLOP [I don't think it'll be] it'll take a few hundred Million $ to find out.
So let's START Shipping ABBIE kits & licensing deals ASAP!

Also:- It would be good for the company to publish that research poster[on their website], for some of us.

The company is actively exploring, negotiating, and collaborating with several Japanese companies to expand its business.

This expansion includes the utilization of gene-editing technology called ABBIE, as well as licensing opportunities.

The management remains committed to…

— SOHM, Inc. (@sohminc) March 19, 2024

$KYNC: DemoMAN: The guy [Wilson] has 100M prefered shs...
You'd think he'd want a higher PPS...at least in PENNYLAND!

Especially with Crypto surging!

$USEI: Acme: LT*C came back from CE and went to PENNYLAND [Almost] despite having an O/S of 15B!
CAN'T make that up!

It's coming here soon!

$SHIB: How do you buy $DAMN & how's it related to $SHIB?
I already own $SHIB
Thanks!

$TONR: You're right... we're on the same page....the BUILD BACK BETTER Guy....aka
*JB !

He's a HARDWORKING Superstar!

$KYNC:; Demo: I go back & forth between CA & FL.
I'll be in FL until End of Apr.

$KYNC: Batman: For those with 'X' accounts...go over & ask questions publicly!
I would but I don't have an account.
WTF is this B.S.?

$TONR: RDW: Oh did he? That makes sense.
But the PPS won't do well with this uncertainty hanging over the merger news.
It's a matter of time, and only that...but OTC trades are very short on patience, as is.
So there's that.
I'll watch the presentation. Looks like it's recorded.

Thanks!

$TONR: WV: Looks like the Zoom ppt did nothing [POSITIVE] to the PPS!

Did anyone from the company talk about the delay in Merger(s)?
Or "Imminent" new leadership?

W/O the above the PPS will gradually drift lower. IMO.

$TONR: train21: M&A's are NOT a slam dunk...especially in so far as time is concerned!

Folks here want everything like they're ordering FAST-FOOD!
Like someone stated...It's going to be a Marathon NOT a sprint!
We're almost in Q2...by End of Q2 we should see deals close for sure.

BTW:- STERVC...you still here?

$USEI: Acme: I would recommend to SLO that he hold his breath!

And SLO...WLY...let the air BACK into his lungs! 😁
The answer will then be obvious to him.

>>How do you know air exists slo

$SHMN: Don't FALL for the Gloom n' Doom guys...
Things seem to be on the move here. This is going to be my last post for a while ...maybe '3' months or so.
There's No f-ing way this stays with a ridiculous mkt cap as it is currently.
And BTW ask your questions/concerns on ''X...looks like they enabled replies.
Good Luck to all!
Again...Don't FALL for the Gloom n' Doom!

$USEI: ACME: Looks like the resurrection is IMMINENT!

$CBIA: P2Stacks: Thx for the DD!
I took a starter position last week.
Any idea why the PPS tanked last Summer?
Was it an R/S or was it MASSIVE Dilution, like what's happening now?
Any input is appreciated!

TIA!

$TONR:: Murphy:;I can throw in a few too!
Looks like he goes around from brd to brd...
Asking for a handout!

$KYNC: Bullish: Seems like it! Lagging behind here...but ONE PR with MoonPay or other FinTECH association...&: we're off to the races!
The company X'd recently about imminent NEWS!
Fingers crossed!